Antibody response to recombinant hepatitis B surface antigen in healthy adults following primary and supplementary vaccination

Iranian Journal of Medical Sciences

Volumn 26, Issue 1-2, 2001, Pages 10-15

  Shakrgozar, M A ^a   Shokri, F ^b  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti HBs antibody; Hepatitis B virus; Vaccination

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; RECOMBINANT HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; MALE; NEWBORN PERIOD; NORMAL HUMAN; REVACCINATION; VACCINATION;

EID: 0034813052     PISSN: 02530716     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Is there a need for boosters of hepatitis B vaccine
2. Seroepidemiology of hepatitis B, delta and HIV infections in Hamadan province of Iran
3. Expanded program on immunization
4. Hepatitis B vaccine: Current issues
5. Immunogenicity of recombinant hepatitis B vaccine in Iranian neonates: High frequency of unresponsiveness independent of the carier state of mothers
6. High rate of seroconversion following administration of a single supplementary dose of recombinant hepatitis B vaccine
7. Immunogenicity of recombinant yeast-derived hepatitis B vaccine in nonresponders to perinatal immunization
8. Response to supplementary vaccination with recombinant or plasma hepatitis B vaccine in healthy non-responding children
9. Revaccination against hepatitis B virus of non-responding and low-responding infants immunized at birth. A parallel evaluation of rubella and tetanus vaccine
10. Persistence of anti-HBs in children vaccinated against viral hepatitis B in the first year of life: Follow-up at 5 and 10 years
11. Lack of response to recombinant hepatitis B vaccine in nonresponders to the plasma vaccine
12. Nonresponsiveness to hepatitis B vaccine in health care workers: Results of re-vaccination and genetic typings
13. Immunization of staff of a regional blood transfusion center with a recombinant hepatitis B vaccine
14. Randomized comparative trial of interferon-alfa versus placebo in hepatitis B vaccine non-responders and hyporesponders
15. Seroconversion after additional vaccine doses to non-responders to three doses of intradermally or intramuscularly administered recombinant hepatitis B vaccine
16. The influence of host factors and immunogenetics on lymphocyte responses to Hepagene vaccination
17. Binding specificity of a class II-restricted hepatitis B epitope by DR molecules from responder and non-responder vaccine recipients
18. Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines
19. Non-responders to hepatitis B vaccine can present envelope particles to T lymphocytes
20. Hepatitis B virus immunopathogenesis
21. Is a function of the secreted HBe antigen to induce immunological tolerance in utero
22. HLA-associated antibody response to recombinant hepatitis B vaccine in Iranian healthy adult individuals
23. Failure of neonatal hepatitis B vaccination: The role of HBV DNA levels in hepatitis B carrier mothers and HLA in neonates
24. Transplacental passage of HBV DNA from HBe antigen-negative mothers and delayed immune response in newborns
25. Is nonresponsiveness to hepatitis B vaccine due to latent hepatitis B virus infection
26. Lymphotropism of hepatitis B and C viruses: An update and a newcomer
27. Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection
28. Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes
29. Neonatal tolerance revisited: Turning on newborn T cells with dendritic cells
30. Complex cytokine responses to hepatitis B surface antigen and tetanus toxoid in responders, non-responders and subjects naive to hepatitis B surface antigen